PI Name Sort descending PI Organization Title Grant Number Initiative Program Director
Maclean, Paul S

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-02 PAR-21-035 (R01 Clinical Trial Required) Young Kim, Ph.D.
Marchand, Loic Le

University Of Hawaii At Manoa
United States

Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial 5R01CA258179-02 RFA-CA-20-004 (R01 Clinical Trial Optional) Gabriela Riscuta, M.D., C.N.S.
Mason, Joel B

Tufts University Boston
United States

Colorectal tumorigenesis on a cricket powder-based diet versus diets based on more typical protein sources 5R03CA252672-02 Amit Kumar, Ph.D.
Panda, Satchidananda

Salk Institute For Biological Studies
United States

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function 5R01CA258221-02 RFA-CA-20-004 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Rosenberg, Daniel William

University Of Connecticut Sch Of Med/Dnt
United States

Microbiota, Metabolites, and Colon Neoplasia 5R01CA252045-02 PA-18-902 (R01 Clinical Trial Optional) Amit Kumar, Ph.D.
Rozengurt, Juan Enrique

University Of California Los Angeles
United States

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression 1R21CA258125-01A1 Gabriela Riscuta, M.D., C.N.S.
Ryan, Elizabeth P

Colorado State University
United States

Rice Bran Microbial Metabolism for Colon Chemoprevention 5R01CA201112-05 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Shalon, Tidhar Dari

Envivo Bio Inc
United States

Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring 1R21CA260665-01A1 PAR-20-133 Sharon Ross, Ph.D., M.P.H.
Shinde, Rahul Suresh

Wistar Institute
United States

The role of gut microbe-derived choline metabolites in driving the pro-inflammatory macrophage phenotype and restricting pancreatic cancer 5R21CA259240-02 PAR-19-199 (R21 Clinical Trial Not Allowed) Gabriela Riscuta, M.D., C.N.S.
Shureiqi, Imad

University Of Michigan At Ann Arbor
United States

ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism 5R01CA266223-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.